TGFB1 抗体 (AA 336-385)
-
- 抗原 See all TGFB1 抗体
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
抗原表位
- AA 336-385
-
适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This TGFB1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- 特异性
-
TGF beta1 Antibody detects endogenous levels of total TGF beta1 protein.
- 纯化方法
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
- 纯度
- > 95 %
- 免疫原
- The antiserum was produced against synthesized peptide derived from human TGF beta1.
- 亚型
- IgG
- Top Product
- Discover our top product TGFB1 Primary Antibody
-
-
- 应用备注
- WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:5000
- 说明
-
Unigene-Number: Hs.645227 (NCBI Gene Symbol: TGFB1)
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Stable at -20°C for at least 1 year.
- 有效期
- 12 months
-
-
Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis." in: Cellular immunology, Vol. 279, Issue 1, pp. 70-7, (2012) (PubMed).
: "
-
Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis." in: Cellular immunology, Vol. 279, Issue 1, pp. 70-7, (2012) (PubMed).
-
- 抗原
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
- 别名
- TGF Beta1 (TGFB1 产品)
- 背景
-
Synonyms: CED, diaphyseal dysplasia 1, progressive, DPD1, TGF-beta 1, TGFB, transforming growth factor, beta 1, transforming growth factor, beta 1 (Camurati-Engelmann disease)
NCBI Gene Symbol: TGFB1
- 分子量
- 44 kDa
- 基因ID
- 7040
- OMIM
- 131300
- UniProt
- P01137
- 途径
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
-